Bioceres Crop Solutions Corp. (BIOX)

Bioceres Crop Solutions Income Statement

Financials in millions USD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Revenue	415.71	334.8	209.53	173.09	160.61
Revenue Growth (YoY)	24.16%	59.79%	21.05%	7.77%	20.27%
Cost of Revenue	235.46	208.36	118.64	93.58	86.96
Gross Profit	180.25	126.44	90.88	79.52	73.64
Selling, General & Admin	113	77.48	47.6	38.35	39.24
Research & Development	15.35	6.95	5.62	4.2	3.69
Other Operating Expenses	-1.08	3.28	0.28	0.31	-0.37
Operating Expenses	127.26	87.71	53.5	42.85	42.57
Operating Income	52.99	38.73	37.39	36.67	31.07
Interest Expense / Income	35.08	25.81	27.85	32.7	41.46
Other Expense / Income	0.2	2.15	2.05	-1.6	-1.01
Pretax Income	17.71	10.77	7.48	5.57	-9.37
Income Tax	-1.07	17.97	14.35	2.21	6.99
Net Income	18.78	-7.2	-6.87	3.36	-16.36
Shares Outstanding (Basic)	63	42	39	36	30
Shares Outstanding (Diluted)	-	42	39	36	30
Shares Change	49.71%	7.86%	7.69%	19.48%	8.47%
EPS (Basic)	0.30	-0.17	-0.17	0.09	-0.60
EPS (Diluted)	0.30	-0.17	-0.17	0.09	-0.60
Free Cash Flow	-19.39	-24.08	-12.61	6.46	27.29
Free Cash Flow Per Share	-0.31	-0.57	-0.32	0.18	0.90
Gross Margin	43.36%	37.76%	43.38%	45.94%	45.85%
Operating Margin	12.75%	11.57%	17.84%	21.18%	19.35%
Profit Margin	4.52%	-2.15%	-3.28%	1.94%	-10.19%
Free Cash Flow Margin	-4.66%	-7.19%	-6.02%	3.73%	16.99%
Effective Tax Rate	-6.03%	166.83%	191.83%	39.65%	-
EBITDA	72.18	45.77	41.6	43	36.91
EBITDA Margin	17.36%	13.67%	19.85%	24.84%	22.98%
Depreciation & Amortization	19.39	9.19	6.26	4.73	4.83
EBIT	52.79	36.58	35.33	38.27	32.09
EBIT Margin	12.70%	10.93%	16.86%	22.11%	19.98%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).